Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
73
NCT04783181
A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jul 1, 2021
Completion: Feb 28, 2029
NCT05101902
A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])
Phase: N/A
Completion: Aug 7, 2024